Third International Conference on Quality in Medicine, Global Health and Law

The Role of Interprofessional Collaboration in Improving Quality of Care in the Time of Pandemic

The goal of the annual conferences on Quality in Medicine, Global Health and Law held at the Scientific Center of the Polish Academy of Sciences (Polska Akademia Nauk, PAN) in Paris, is to facilitate productive collaboration among healthcare organizations and academic centers in Poland, France, as well as other countries around the globe.

After a productive and inspiring Roundtable Meeting on Quality Improvement in Medicine held at the PAN Paris Scientific Center in April 2018, the Second PAN Paris International Conference on Quality Improvement in Medicine was held on May 15 and 16, 2019, and was focused on the role of international collaboration in improving quality of care.

The goal of the Third International Conference on Quality in Medicine, Global Health and Law held at the Polish Academy of Sciences Center in Paris on June 14-16, 2021 was to explore the role of interprofessional collaboration in addressing the scientific, ethical, legal, social and managerial challenges emerging in the midst of an unprecedented global epidemiological crisis going on since the beginning of 2020.

The Conference was designed to capture an instantaneous snapshot of the current situation as seen by a multidisciplinary ensemble of professionals representing a variety of backgrounds, cultures, countries, and points of view. Three Keynote Speakers set the stage by presenting the essence of the pandemic from the global, French and Polish perspective. Five Roundtable discussions gave the audience an understanding of how the pandemic changed the policies and research priorities of leading global and regional organizations confronting the biggest challenge of our times.

Finally, ten Interactive Panels were designed to provide information and inspiration from professionals other than frontline medical scientists and frontline healthcare workers. The Panelists were asked to give short presentations describing the essence of their professional endeavors and lessons learned in the midst of the geo-political and epidemiological tsunami. The common baseline framework of the discussions was anchored in the concept of quality of care defined as the degree to which the services provided to individual patients and entire populations are in compliance with four specific criteria: current scientific knowledge, professional ethical standards, applicable law, and principles of fairness and equity. The ultimate goal of the meeting was the promotion of the scientific, academic, clinical and organizational excellence in addressing the essence of the current epidemiological crisis, with a specific emphasis on the role of innovative technologies in improving the quality of care.

The discipline of quality management plays an essential role in effective functioning of the healthcare organizations. The first formal initiatives in this field were undertaken in Western Europe, Japan and the United States in the early 1970s, inspired by the quality control methods used in the manufacturing industry. Nowadays, hundreds of governmental agencies, non-profit, and community organizations around the world pursue research and implementation of various healthcare quality monitoring and improvement programs.

The first healthcare quality management initiatives undertaken in Poland in the early 1990s by the Polish Ministry of Health, resulted in the creation of the National Society for Quality Management in Healthcare in 1993, and in the establishment of the National Center for Healthcare Quality Monitoring in Krakow in 1994. The Center provides an essential administrative infrastructure for the training and accreditation purposes in the field of healthcare quality monitoring in Poland. Nevertheless, an ongoing training of healthcare professionals in various aspects of quality management is necessary. It can be effectively accomplished through the international collaboration encouraging the exchange of research results and ideas.

The goal of the annual conferences on Quality in Medicine, Global Health and Law held at the Scientific Center of the Polish Academy of Sciences in Paris, France, is to facilitate such collaboration among healthcare organizations and academic centers in Poland and the United States as well as other countries around the globe.

After a productive and inspiring Roundtable Meeting on Quality Improvement in Medicine held at the PAN Paris Scientific Center in April 2018, the Second PAN Paris International Conference on Quality Improvement in Medicine was held on May 15 and 16, 2019, and was focused on the role of international collaboration in improving quality of care. Programs and reports from the 2018 and 2019 conferences are available here:

Booklet 2018
Meeting Report 2018

Booklet 2019
Meeting report 2019

The goal of the third PAN Paris Conference on Quality in Medicine, Global Health and Law, scheduled for June 14-16, 2021, is to explore the role of interprofessional collaboration in improving quality of care in the time of the current pandemic. The invited speakers will represent academic, governmental, corporate, and academic entities in Poland, the United States, as well as other countries in Europe, Africa, Asia, and the Americas.

The goal of the Conference is to explore the role of interprofessional collaboration in addressing the scientific, ethical, legal, social and managerial challenges emerging in the midst of an unprecedented global epidemiological and political crisis, which we have been experiencing since the beginning of 2020.

These unusually difficult times call for an unusual and novel approach to scientific gatherings. This Conference is designed to capture an instantaneous snapshot of the current situation as seen by a multidisciplinary ensemble of professionals representing a variety of backgrounds, cultures, countries, and points of view.

Our three Keynote Speakers will set the stage by presenting the essence of the pandemic from the global, French and Polish perspective.

The five Roundtable discussions are expected to give the audience an understanding of how the pandemic changed the policies and research priorities of leading global and regional organizations confronting the biggest challenge of our times.

Finally, the ten Interactive Panels are designed to provide information and inspiration from professionals other than frontline medical scientists and frontline healthcare workers. The Panelists will be asked to give short 10- minute presentations (not quite an elevator speech, but close) describing the essence of their professional endeavors and lessons learned in the midst of the geo-political and epidemiological tsunami.

It will be the Moderators’ job to ensure that the common baseline framework of our discussions will be anchored in the concept of quality of care defined as the degree to which the services provided to individual patients and entire populations are in compliance with four specific criteria: current scientific knowledge, professional ethical standards, applicable law, and principles of fairness and equity.

While doing this, we will aim at achieving measurable results of our encounter, such as obtaining the EU and other international funding for collaborative, multicenter research, academic exchange opportunities for faculty and students, and finally – publications of the results of joint research projects in peer-reviewed journals.

The ultimate goal of this meeting is the promotion of the scientific, academic, clinical and organizational excellence in addressing the crisis, which might very well prove to be the biggest challenge of our professional and personal lives.

Scientific Committee:

• Prof. Christine Huttin, University Aix Marseille, member of the High Council of Public Health, France
• Dr. Małgorzata Nabiałczyk-Chalupowski, MEDYK Publishing House Boston Office, USA
• Dr. Magdalena Sajdak, Polish Academy of Sciences Scientific Center in Paris, Poland

Keynote speakers

Day 1:  Etienne Minvielle 

Pandemic – Global Perspective

Etienne Minvielle received his MD from the Paris V School of medicine where he did his residency in Public Health. He also received a PhD in Management Science from the Polytechnique School, and also be graduated from the French business school, ESSEC. He spent one year at the Leonard Davis Institute, University of Pennsylvania, during his post-doctoral period. He recently became the director of the Master of Science in Health Care Management (EHESP, AP-HP, Ecole du Santé des Armées, Paris VII). His research seeks to understand the effect of new delivery systems (new forms of payment, patient pathways, quality improvement incentives, customized service) on healthcare performance. He has been continuously funded by the French Ministry of Health and the High Authority for Health for developing a national quality program, including quality indicators, ranking methods and paying for quality system, since 2003. He is currently the principal investigator of a cancer navigation research supported by the French Agency for Research which assesses the impact of patient portal on oral drugs’ observance. He is also the coordinator of a study sponsored by the French Agency for Health care Performance for designing a composite score of hospital performance (based on the medico-administrative database named Hospidiag). His research has been published in high-impact peer-reviewed journals (The BMJ, NEJM catalyst, Medical Care, Social Science and Medicine, Public Administration Review, Health Policy). He also published The Quality Imperative (Imperial College Press) with John Kimberly (Wharton School), and recently “Le patient et le Système” (Ed. Seli Arslan). He serves on numerous expert panels advising policy makers and government officials on the use of quality improvement incentives in health care. In addition to his research, Etienne Minvielle is also advisor at Gustave Roussy, a leading European Cancer center, for implementing innovative patient pathways. He works closely with the CEO and the board of directors to help design innovative patient pathways

Day 2: Daria Julkowska

Pandemic – French Perspective

Daria Julkowska has over 15 years of experience in research and management. She is the Scientific Coordinator of the European Joint Programme on Rare Diseases that brings together different type of stakeholders (researchers, funders, clinicians & patients) from 35 countries from Europe and beyond, and also is responsible for the coordination of the IRDiRC Scientific Secretariat. This position allows her to implement the strategic rare disease research and funding recommendations of IRDiRC to the development of EJP RD which includes the participation of the European Research networks. She is involved in the rare diseases field since 2010, starting from E-Rare, the ERA-Net for Research programmes on rare diseases, where for the first two years she occupied the position of the project manager to finally (April 2013-December 2018) take over the coordination of the programme. As the coordinator, she developed and put into action a set of collaborations facilitating rare diseases research, including the partnerships with European Research Infrastructures and Patients’ Organizations. She has an extensive knowledge and understanding of European funding schemes and programmes. Dr. Julkowska obtained her international PhD in molecular biology at the University of Paris XI, France and University of Gdansk, Poland in 2005. She pursued her scientific vocation by the post-doctoral experience in cellular biology, at Institut Pasteur, Paris and extensive training in communication and European Union counselling. She also holds MSc in Management of Research from the University of Paris Dauphine. In 2020 she received EURORDIS Back Pearls European Rare Diseases Leadership Award.

Day 3: Krzysztof Pyrć

Pandemic – Polish Perspective

Krzysztof Pyrć is a virologist. Graduated from Jagiellonian University (M.Sc.), University of Amsterdam (Ph.D.), and University of Lodz (habilitation). In January 2019 received the title of Professor in the field of biological sciences. He specializes in emerging RNA viruses (mainly coronaviruses and flaviviruses), with particular emphasis on mechanisms of infection and the development of new therapeutic strategies. Head of the Laboratory of Virology at the Malopolska Centre of Biotechnology, Jagiellonian University. A certified project manager. Leader of Virogenetics research group, supervisor, and promoter of students and Ph.D. students. Authored over 100 publications in journals as Nature Medicine, Science Translational Medicine, PNAS, PloS Pathogens, Journal of Virology, or Science Signaling, which have been cited nearly four thousand times in the world literature. Reviewer and expert in science funding institutions in Poland and abroad (Horizon2020, ERC, FNP, NCN, and others). Author of several patent applications and patents, on the basis of which 2 spin-off companies have already been established (Acatavir and StartIt Vet).

Manager and coordinator of numerous research grants, including under Horizon2020, IMI2, European Cooperation in Science and Technology, NCN, FNP, NCBIR, and MNiSW, as well as grants funded by commercial entities.

Member of the advisory team of the Minister of Science and Higher Education for activities related to the prevention, counteraction, and eradication of COVID-19. Deputy chairman of the advisory team (COVID-19) to the President of the Polish Academy of Sciences, member of the scientific board of the initiative Science against Pandemic. Member of the Medical Council to the Prime Minister. Expert of the Agency for Health Technology Assessment and Tarification – AOTMiT in the field of SARS-CoV-2 therapy and diagnostics.

Co-Organizer:

Partner:

Sponsor: